Quantum redactiones paginae "Erythropoietinum" differant

Content deleted Content added
pag. inst.
 
mNo edit summary
Linea 16:
| style="font-size: 85%; background-color: #C3B091" | Substratum || colspan="5" style="font-size: 85%" | [[proteinum praecursor amyloidi]] (''APP'')
|-
| style="font-size: 85%; background-color: #C3B091" | Fontes externae || colspan="5" style="font-size: 85%" | OMIM: [https://omim.org/entry/604252133170 604252133170]
|}
'''Erythropoietinum''' sive '''EPO''' sive '''haematopoietinum''' est [[glycoproteinum]] et [[cytokinum]] responsum hypoxiae in renibus secretum. Effectus EPO est generationem in [[medulla ossium]] novorum cellularum per [[receptorium erythropoietini]] sanguinearum rubrarum ([[erythrocytus|erythrocytarum]]), quod ''[[erythropoiesis]]'' dicitur<ref>{{cite journal |authors=Elliott S., Sinclair A. M. |title=The effect of erythropoietin on normal and neoplastic cells |journal=Biologics |year=2012 |volume=6 |pages=163-89 |url=https://www.ncbi.nlm.nih.gov/pubmed/22848149}}</ref>.